학술논문
Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52
Document Type
Article
Author
Source
In: International Forum of Allergy and Rhinology . (International Forum of Allergy and Rhinology, March 2024, 14(3):668-678)
Subject
Language
English
ISSN
20426984
20426976
20426976